Posted in | News | Materials Processing | Fibers

CTG/Taishan Fiberglass Commences Production of S-1 HM Glass Fiber Developed by AGY

AGY, a leading global producer of glass fiber yarns and glass fiber reinforcements, has announced the start of production of S-1 HM™ glass in conjunction with CTG/Taishan Fiberglass.

Mr. Drew Walker, President and CEO of AGY (left) shakes hands with Mr. Zhiyao Tang, Chairman and President of CTG/Taishan Fiberglass (right) confirming the launch of S-1 HM™ glass fiber production.

The material was developed by AGY and will be produced by CTG/Taishan Fiberglass to fill the cost and performance gap between traditional E-Glass products and higher performance glasses such as AGY’s S-2 Glass®  products.

CTG/Taishan Fiberglass is one of the world’s largest glass fiber manufacturers whose main focus is supplying the highest quality glass fiber to its customers at the best price and with the best service. “We are looking forward to working with AGY and producing S-1 HM glass,” said Mr. Zhiyao Tang, Chairman and President of CTG/Taishan Fiberglass.

S-1 HM glass was developed primarily for the wind energy market with input from blade and turbine manufactures. While AGY and CTG/Taishan Fiberglass are targeting the wind energy market with S-1 HM, they both believe the material has potential for many other industrial applications. “Since S-1 HM glass is mechanically superior to E-Glass, but much less expensive than the extremely high-end glasses, we feel that S-1 HM will be an excellent fit for composite manufacturers in a wide variety of markets,” said Drew Walker, CEO of AGY.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.